MEDICOPharmaceuticals
Medico Remedies Ltd — Cash Flow Statement
₹32.76
-7.47%
Medico Remedies Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 1.70 Cr | -0.04 Cr | 1.57 Cr | -0.05 Cr | — |
| Capital Expenditure | -3.19 Cr | -2.48 Cr | -6.59 Cr | -5.91 Cr | — |
| End Cash Position | 1.09 Cr | 0.18 Cr | 0.91 Cr | 1.17 Cr | — |
| Beginning Cash Position | 0.18 Cr | 0.91 Cr | 1.17 Cr | 2.83 Cr | — |
| Changes In Cash | 0.91 Cr | -0.73 Cr | -0.25 Cr | -1.67 Cr | — |
| Financing Cash Flow | -0.52 Cr | -0.49 Cr | -1.82 Cr | -5.77 Cr | — |
| Investing Cash Flow | -3.46 Cr | -2.68 Cr | -6.60 Cr | -1.76 Cr | — |
| Net Other Investing Changes | 25000.00 | -0.20 Cr | — | 1000.00 | — |
| Interest Received Cfi | 0.10 Cr | 0.09 Cr | 0.07 Cr | 0.06 Cr | — |
| Net Investment Purchase And Sale | -0.09 Cr | -0.10 Cr | -0.09 Cr | -0.01 Cr | — |
| Sale Of Investment | 26000.00 | — | — | 0.00 | 0.15 Cr |
| Purchase Of Investment | -0.09 Cr | -0.10 Cr | -0.09 Cr | -0.01 Cr | — |
| Net PPE Purchase And Sale | -3.18 Cr | -2.47 Cr | -6.59 Cr | -2.90 Cr | — |
| Sale Of PPE | 40000.00 | 80000.00 | 45000.00 | 3.01 Cr | — |
| Purchase Of PPE | -3.19 Cr | -2.48 Cr | -6.59 Cr | -5.91 Cr | — |
| Operating Cash Flow | 4.89 Cr | 2.44 Cr | 8.17 Cr | 5.86 Cr | — |
| Taxes Refund Paid | -3.80 Cr | -3.17 Cr | -2.50 Cr | -1.79 Cr | — |
| Change In Working Capital | -7.25 Cr | -9.26 Cr | -2.15 Cr | -1.34 Cr | — |
| Change In Other Current Liabilities | 10.88 Cr | -0.03 Cr | -0.19 Cr | -0.70 Cr | — |
| Change In Other Current Assets | -3.98 Cr | 0.64 Cr | 0.76 Cr | 4.90 Cr | — |
| Change In Payable | 3.20 Cr | 0.53 Cr | 3.89 Cr | 1.75 Cr | — |
| Change In Inventory | -10.39 Cr | 3.36 Cr | -1.59 Cr | -3.56 Cr | — |
| Change In Receivables | -6.96 Cr | -13.66 Cr | -5.56 Cr | -3.88 Cr | — |
| Other Non Cash Items | -0.02 Cr | 0.03 Cr | 0.13 Cr | 0.23 Cr | — |
| Provisionand Write Offof Assets | -0.58 Cr | 0.63 Cr | -0.14 Cr | 0.03 Cr | — |
| Deferred Tax | 3.41 Cr | 3.04 Cr | 2.86 Cr | 1.67 Cr | — |
| Depreciation And Amortization | 3.03 Cr | 2.88 Cr | 5.44 Cr | 4.44 Cr | — |
| Depreciation | 3.03 Cr | 2.88 Cr | 5.44 Cr | 4.44 Cr | — |
| Pension And Employee Benefit Expense | 63000.00 | — | — | 0.00 | 0.00 |
| Gain Loss On Sale Of PPE | 2000.00 | -34000.00 | 12000.00 | 0.04 Cr | — |
| Net Income From Continuing Operations | 10.09 Cr | 8.29 Cr | 7.24 Cr | 4.81 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -0.24 Cr | 20000.00 | — | 1.00 |
| Interest Paid Cff | — | 0.00 | -0.05 Cr | -0.23 Cr | -0.92 Cr |
| Repayment Of Debt | — | — | -1.30 Cr | -5.39 Cr | — |
| Net Other Financing Charges | — | — | -1.30 Cr | 1000.00 | -2.07 Cr |
| Net Issuance Payments Of Debt | — | — | -1.30 Cr | -5.39 Cr | 15.05 Cr |
| Net Long Term Debt Issuance | — | — | -1.30 Cr | -5.39 Cr | 4.95 Cr |
| Long Term Debt Payments | — | — | -1.30 Cr | -5.39 Cr | — |
| Issuance Of Debt | — | — | — | 0.00 | 15.05 Cr |
| Issuance Of Capital Stock | — | — | — | 12.45 Cr | 4.15 Cr |
| Net Common Stock Issuance | — | — | — | 12.45 Cr | 4.15 Cr |
| Common Stock Issuance | — | — | — | 12.45 Cr | 4.15 Cr |
| Net Short Term Debt Issuance | — | — | — | -0.39 Cr | 10.10 Cr |
| Short Term Debt Payments | — | — | — | -0.39 Cr | — |
| Long Term Debt Issuance | — | — | — | 0.00 | 4.95 Cr |
| Short Term Debt Issuance | — | — | — | — | 10.10 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Medico Remedies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.